Evidence map›Paper›PMID 29710195›Full record

ArticleJAMA oncology2018

Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.

Ola Landgren, Rachel Zeig-Owens, Orsolya Giricz, David Goldfarb, Kaznouri Murata, Katie Thoren, Lakshmi Ramanathan, Malin Hultcrantz, Ahmet Dogan, George Nwankwo and 12 more

Open access · hybridAbstract read
In one paragraph

Article in JAMA oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Metabolic Disorders in Multiple Myeloma.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. World Trade Center Health Program: First Decade of Research.International journal of environmental research and public health · 2020
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 1 country.

Ola LandgrenMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Rachel Zeig-OwensDepartment of Medicine, Montefiore Medical Center, Bronx, New York.
Orsolya GiriczDivision of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
David GoldfarbDepartment of Medicine, Montefiore Medical Center, Bronx, New York.
Kaznouri MurataDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Katie ThorenDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Lakshmi RamanathanDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Malin HultcrantzMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Ahmet DoganDepartment of Hematopathology, Memorial Sloan Kettering Cancer Center, New York, New York.
George NwankwoDivision of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Ulrich SteidlDivision of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Kith PradhanDivision of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Charles B HallDivision of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Hillel W CohenDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.
Nadia JaberBureau of Health Services, Fire Department of the City of New York, Brooklyn, New York.
Theresa SchwartzDepartment of Medicine, Montefiore Medical Center, Bronx, New York.
Laura CrowleyMount Sinai School of Medicine, New York, New York.
Michael CraneMount Sinai School of Medicine, New York, New York.
Shani IrbyDepartment of Hematopathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Mayris P WebberDepartment of Medicine, Montefiore Medical Center, Bronx, New York.
Amit VermaDivision of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
David J PrezantBureau of Health Services, Fire Department of the City of New York, Brooklyn, New York.
Memorial Sloan Kettering Cancer Center · USAlbert Einstein College of Medicine · USNew York City Fire Department · USMontefiore Medical Center · USIcahn School of Medicine at Mount Sinai · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NIOSH CDC HHS U01 OH011933
6 · The paper itself

Abstract

Importance: The World Trade Center (WTC) attacks on September 11, 2001, created an unprecedented environmental exposure to known and suspected carcinogens suggested to increase the risk of multiple myeloma. Multiple myeloma is consistently preceded by the precursor states of monoclonal gammopathy of undetermined significance (MGUS) and light-chain MGUS, detectable in peripheral blood. Objective: To characterize WTC-exposed firefighters with a diagnosis of multiple myeloma and to conduct a screening study for MGUS and light-chain MGUS. Design, Setting, and Participants: Case series of multiple myeloma in firefighters diagnosed between September 11, 2001, and July 1, 2017, together with a seroprevalence study of MGUS in serum samples collected from Fire Department of the City of New York (FDNY) firefighters between December 2013 and October 2015. Participants included all WTC-exposed FDNY white, male firefighters with a confirmed physician diagnosis of multiple myeloma (n = 16) and WTC-exposed FDNY white male firefighters older than 50 years with available serum samples (n = 781). Exposures: WTC exposure defined as rescue and/or recovery work at the WTC site between September 11, 2001, and July 25, 2002. Main Outcomes and Measures: Multiple myeloma case information, and age-adjusted and age-specific prevalence rates for overall MGUS (ie, MGUS and light-chain MGUS), MGUS, and light-chain MGUS. Results: Sixteen WTC-exposed white male firefighters received a diagnosis of multiple myeloma after September 11, 2001; median age at diagnosis was 57 years (interquartile range, 50-68 years). Serum/urine monoclonal protein isotype/free light-chain data were available for 14 cases; 7 (50%) had light-chain multiple myeloma. In a subset of 7 patients, myeloma cells were assessed for CD20 expression; 5 (71%) were CD20 positive. In the screening study, we assayed peripheral blood from 781 WTC-exposed firefighters. The age-standardized prevalence rate of MGUS and light-chain MGUS combined was 7.63 per 100 persons (95% CI, 5.45-9.81), 1.8-fold higher than rates from the Olmsted County, Minnesota, white male reference population (relative rate, 1.76; 95% CI, 1.34-2.29). The age-standardized prevalence rate of light-chain MGUS was more than 3-fold higher than in the same reference population (relative rate, 3.13; 95% CI, 1.99-4.93). Conclusions and Relevance: Environmental exposure to the WTC disaster site is associated with myeloma precursor disease (MGUS and light-chain MGUS) and may be a risk factor for the development of multiple myeloma at an earlier age, particularly the light-chain subtype.

Indexed as

DisastersEnvironmental Restoration and RemediationFirefightersRescue WorkSeptember 11 Terrorist AttacksAdultAgedAge DistributionAge of OnsetAir PollutantsAntigens, CD20HumansImmunoglobulin Light ChainsMaleMiddle AgedMinnesotaAir PollutantsAntigens, CD20Immunoglobulin Light ChainsMyeloma Proteins

Identifiers

PMID29710195
PMCPMC6145680
OpenAlexW2800401622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.